Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like AstraZeneca Partners Up With Chinese Fund to Launch New Biopharma Company November 26, 2017 Backed By Two Drug Powerhouses, GenSight Alum Launches New Biotech With $40 Million May 3, 2017 FDA Release: Mutual Recognition Promises New Framework For Pharmaceutical Inspections For United States And European Union March 1, 2017
FDA Release: Mutual Recognition Promises New Framework For Pharmaceutical Inspections For United States And European Union March 1, 2017
